Literature DB >> 2124065

Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants.

J Brismar1, A Aqeel, G Brismar, R Coates, G Gascon, P Ozand.   

Abstract

Ten infants with classical maple syrup urine disease (MSUD) and two with variant MSUD had a total of 26 CT scans and 13 MR examinations of the brain during different stages of their disease. We found that inter- and intrapatient analyses of CT and MR findings at times ranging from 3 days to 7 months were typical enough to suggest the MSUD diagnosis. Imaging studies showed the natural course of the disease and, in a few cases, illustrated the effects of therapy. CT scans typically are negative during the first few days of life, then a marked, generalized, diffuse edema appears. In addition, a localized, more severe edema (the MSUD edema) is seen, which involves the deep cerebellar white matter, the dorsal part of the brainstem, the cerebral peduncles, and the dorsal limb of the internal capsule. Both the generalized and the MSUD edema subside during the second month of life, then may disappear totally or leave a well-defined, low-density zone around the lateral ventricles and small, low-attenuation lesions within the brainstem, respectively. With the disappearance of the edema, some loss of brain substance becomes obvious.

Entities:  

Mesh:

Year:  1990        PMID: 2124065      PMCID: PMC8332126     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment.

Authors:  Kenneth A Myers; Melanie Reeves; Xing-Chang Wei; Aneal Khan
Journal:  JIMD Rep       Date:  2011-09-22

Review 2.  Dentate Update: Imaging Features of Entities That Affect the Dentate Nucleus.

Authors:  K M Bond; W Brinjikji; L J Eckel; D F Kallmes; R J McDonald; C M Carr
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  Imaging in neonatal maple syrup urine disease.

Authors:  Puneet Jain; Suvasini Sharma; Naveen Sankhyan; Neerja Gupta; Madhulika Kabra; Sheffali Gulati
Journal:  Indian J Pediatr       Date:  2012-08-04       Impact factor: 1.967

4.  Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.

Authors:  Rukiye Kilicarslan; Alpay Alkan; Demet Demirkol; Huseyin Toprak; Rasul Sharifov
Journal:  Jpn J Radiol       Date:  2012-04-03       Impact factor: 2.374

5.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 6.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

7.  MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.

Authors:  Wajanat Jan; Robert A Zimmerman; Zhiyue J Wang; Gerard T Berry; Paige B Kaplan; Edward M Kaye
Journal:  Neuroradiology       Date:  2003-05-08       Impact factor: 2.804

8.  Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.

Authors:  Jong Su Ha; Taik-Kun Kim; Baik-Lin Eun; Hee Sun Lee; Ki Yeol Lee; Hae Young Seol; Sang Hoon Cha
Journal:  Pediatr Radiol       Date:  2003-09-18

9.  Structural white matter changes in adolescents and young adults with maple syrup urine disease.

Authors:  D Klee; E Thimm; H J Wittsack; D Schubert; R Primke; G Pentang; J Schaper; U Mödder; A Antoch; U Wendel; M Cohnen
Journal:  J Inherit Metab Dis       Date:  2013-01-25       Impact factor: 4.982

10.  An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist.

Authors:  Rita Christopher; Bindu P Sankaran
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.